Human papillomavirus (HPV) DNA, originally isolated from patients suffering from the skin disease epidermodysplasia verruciformis (EV), and a growing number of related sequences have recently been detected in a high percentage of benign and malignant skin lesions of both immunosuppressed and immunocompetent people. HPV L1 DNA fragments (374-389 bp long) from a solar keratosis and a squamous cell carcinoma (SCC) of a renal transplant recipient were amplified, cloned and sequenced. In 54 clones, six different HPV sequences were identified. One of these six corresponded to the known type HPV-8 and two (RTRX3 and RTRX7) have been described previously in cutaneous lesions of immunosuppressed patients. The remaining three sequences were different from all known HPV types : an HPV-9-related sequence (77n4 % identity), an RTRX2-related sequence
Introduction
Human papillomaviruses (HPVs) represent a large group of DNA viruses causing proliferative epithelial lesions at various anatomical sites (Pfister & Fuchs, 1994) . Members of HPV group A are primarily associated with benign and malignant lesions in the anogenital tract. A further group was originally isolated from characteristic skin lesions of patients suffering from the rare hereditary disease epidermodysplasia verruciformis (EV) (Jablonska et al., 1972) . These viruses are therefore Author for correspondence : Herbert Pfister.
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(82n6 % identity), and an HPV-22-related sequence (83n7 % identity). These three sequences, representing putatively new HPV types, were named RTRX8, RTRX9 and RTRX10, respectively. RTRX7 was found in the majority of clones from both lesions. The complete genome of RTRX7 (7731 bp) was cloned as six overlapping subgenomic fragments, generated by nested PCR with DNA extracts from the SCC. RTRX7 showed a genome organization typical of HPVs associated with EV. The L1 DNA sequence differed by 15 % from the corresponding region of its closest known relative, HPV-12 ; thus, RTRX7 can be regarded as a new HPV type. RTRX7 DNA could not be detected by Southern blot hybridization with the homologous probe, indicating that the DNA concentration was below one copy per 10 cells in the investigated SCC.
referred to as EV-associated. Chan et al. (1995) classified them as group B1 papillomaviruses.
Prior to the introduction of highly sensitive PCR techniques, these HPV types were only rarely detected in cutaneous specimens from patients without a history of EV (Pfister, 1992) . With increasingly sensitive methods, a broad spectrum of HPV types has been found in skin tumours of both immunosuppressed and immunocompetent people (Soler et al., 1993 ; Stark et al., 1994 ; Shamanin et al., 1994 Shamanin et al., , 1996 Tieben et al., 1994) . In some studies, EV-associated HPV types and related sequences were detected in a high percentage of cutaneous specimens de Jong-Tieben et al., 1995) . More than 30 % of the PCR-positive samples were shown to harbour more than one HPV type. Using nested PCR with degenerate primers, Berkhout et al. (1995) revealed six unknown HPV sequences (RTRX1-RTRX6) related to EV types in skin lesions of renal transplant recipients, and another such sequence, named ICPX1, in tumours of an immunocompetent patient. Complete genomes of these putatively new HPV types from the EV-associated subgroup are not yet available. The discrepancy between the usually negative results of Southern blot hybridizations for EV-associated HPVs, and their high prevalence in investigations by nested PCR, suggest persistence at low concentrations in cutaneous neoplasia of non-EV patients.
Recent reports by the present authors describe an immunosuppressed renal transplant recipient with numerous skin tumours and reveal, in addition to other types, a new HPV DNA sequence which was closely related to the EV-associated HPV-12 (Ho$ pfl et al., 1996 (Ho$ pfl et al., , 1997 . This sequence was named RTRX7. These findings encouraged close examination of one malignant and one premalignant skin lesion from this patient for the range of HPV types detectable therein, and studies to determine the entire nucleotide sequence of RTRX7 by cloning overlapping subgenomic fragments generated by nested PCR.
Methods
Biopsy material, DNA preparation and PCR amplification of an L1 gene fragment. DNA was extracted from frozen material of one solar keratosis from the neck of an immunosuppressed renal transplant recipient and of one incipient squamous cell carcinoma (SCC) from his cheek using the QIAamp Tissue kit (Qiagen) according to the manufacturer's instructions. Amplification of HPV-specific DNA was carried out using nested PCR and degenerate primer pairs CP65\CP70 and CP66\CP69 (Table 1) designed by Berkhout et al. (1995) . For cloning purposes, a BamHI cleavage site was added to the 5' end of the CP66 oligonucleotide sequence and an EcoRI site was added to the 5' end of CP69. The reaction mixtures (total volume 50 µl) of both external and internal PCR contained 50 mM KCl, 10 mM Tris-HCl (pH 8n8), 3n6 mM MgCl # , 0n005 % gelatine, deoxynucleoside triphosphates (0n2 mM each), 0n9 µM forward primer, 0n9 µM backward primer and 2n5 U of the proofreading Expand High Fidelity polymerase (Boehringer). In the external PCR, 10 µl cellular DNA extract (0n5 µg) was used as input. Five cycles each running for 1 min at 95 mC, 1n5 min at 50 mC and 2 min at 72 mC were followed by 35 cycles of 1 min at 95 mC, 1 min at 55 mC and 2 min at 72 mC. For the internal PCR reaction, 3 µl of the first-step PCR product was used as input. A further amplification was performed in 30 cycles (1 min at 95 mC, 1 min at 55 mC and 2 min at 72 mC). To avoid contamination of the samples during DNA preparation and PCR processing, the suggestions of Kwok (1990) were strictly followed. With each set of PCR reactions, three aliquots of distilled water were processed in the same way as the template DNA in order to monitor any possible DNA carry-over. In addition, DNA was extracted from several EV-HPVnegative biopsies and subjected to PCR as negative controls of the DNA preparation procedure.
Cloning and sequencing of the amplimers. After digestion with BamHI and EcoRI, PCR products were ligated to BamHI\EcoRI-cleaved, dephosphorylated pUC18 vector DNA. These constructs were transformed into competent E. coli DH5α using the CaCl # method (Sambrook et al., 1989) . Plasmid DNA was isolated from transformants using QIAprep8 Miniprep kit (Qiagen). Clones containing inserts of the expected size were identified by double cleavage with BamHI and EcoRI. Both strands of all inserts exhibiting the correct size were sequenced using the T7 Sequencing kit (Pharmacia) and [α-$&S]dATP (Amersham).
Samples were electrophoresed in 8 % polyacrylamide-7 M urea gels, washed with 10 % acetic acid, dried and exposed to Hyperfilm-βmax films (Amersham).
Sequence and phylogenetic analyses. Analyses were performed as described previously (Wieland et al., 1997) . Briefly, translation of nucleotide sequences and sequence alignments were performed with the sequence analysis software MacVector 6.0 and AssemblyLIGN 1.0 (Oxford Molecular Group). The HPV L1 sequences determined were aligned to 111 published HPV reference sequences (Myers et al., 1996) . The percentage of matching nucleotides of aligned sequences of CP66\CP69 amplimers was calculated. The same was done later with all open reading frames (ORFs) of RTRX7.
Phylogenetic analyses were performed with the Heidelberg Unix Sequence Analysis Resources (HUSAR), German Cancer Research Center, Heidelberg, Germany. Sequences to be analysed were aligned using the HUSAR program Clustal V ; the program ClusTree was then used to calculate an unrooted phylogenetic tree according to the neighbourjoining method of Saitou & Nei (1987) . The branch lengths represent the percentage divergence along the respective branches. Bootstrapping was employed on all data sets analysed to evaluate confidence levels for the groupings of a tree (1000 bootstrap replicates for each grouping of a tree ; Felsenstein, 1985) .
Cloning of the complete RTRX7 genome. The complete genome of RTRX7 was cloned in six overlapping fragments, named I1-I6 in order of their amplification (Fig. 1) . The subgenomic fragments I2-I6 were generated by nested PCR with DNA extracts from the SCC. Cycling conditions were the same as those applied for the CP66\CP69 amplimer (I1). Starting from I1, 17-22 nucleotide (nt) primers for the amplification of subsequent fragments were derived from the sequences of the previously amplified fragments, creating overlaps of 56-120 nt in the RTRX7-specific sequence. Primers for the other end of a new fragment were degenerate, but mainly oriented at the HPV-12 sequence, which is the closest relative of RTRX7 known to date. The primers were chosen to be as far as possible from sites conserved among the EV-associated HPVs. In particular, non-conserved residues at the 3h end of the primer annealing sites were avoided. Restriction enzyme cleavage sites were attached to the 5h ends of both internal primers. The forward primer carried an XbaI site and the backward primer a BamHI site. The fragment I6 was amplified with RTRX7-specific primers derived from sequences within I4 and I5, respectively ( Fig. 1 ). Both internal primers carried a SalI cleavage site in this case. Table 1 shows the exact sequences of the PCR primers used, their annealing sites and the size of the amplified subgenomic fragments. PCR products were analysed in 1 % agarose gels stained with ethidium bromide. Bands of the expected size were excised from the gel, and DNA was purified using the QIAquick Gel Extraction kit (Qiagen). The fragments were inserted into pUC18 and transformed into E. coli DH5α. The longer fragments were sequenced using the primer walking strategy which has been described in detail by Delius & Hofmann (1994) . All oligonucleotides used for PCR amplification or sequencing were purchased from Eurogentec.
Southern blot analysis. Cellular DNA (10 µg) extracted from the RTRX7-positive SCC was digested with HindIII, a non-cutter of the RTRX7 genome. Another 10 µg was digested with XbaI, a single cutter of RTRX7. Purified amplimers (0n15, 1n5 and 15 pg) generated by nested PCR with the I2 primers (Table 1) were each added to 10 µg sonicated salmon sperm (SSS) DNA and used as sensitivity standards corresponding to 0n1, 1 and 10 genome equivalents of RTRX7 per cell. All samples were electrophoresed in 1 % agarose, denatured and transferred by vacuum to a nylon membrane (Hybond-N ; Amersham) in an alkaline buffer. Thirty ng of the I2 PCR product was labelled with [α-$#P]dATP using the Gibco Random Primers DNA Labelling system and this served as a homologous Fuchs et al. (1986) and Delius & Hofmann (1994) , respectively. probe. Hybridization was carried out under stringent conditions at 37 mC (25 mC below the T M ) according to standard protocols (Sambrook et al., 1989) . After washing under stringent conditions, the filter was scanned on a Molecular Dynamics PhosphorImager 425 with ImageQuant software version 3.3 (Molecular Dynamics). As a further sensitivity confirmation, a blotted dilution series of 19 ng, 1n9 ng, 190 pg, 19 pg and 1n9 pg (1000-0n1 genome equivalents) of closed circular full-length HPV-8 plasmids (Steger et al., 1990) in 10 µg SSS DNA was hybridized with labelled, HPV-8-specific I2 PCR products.
Results

Spectrum of HPV types in two skin lesions
Nested PCR products obtained with DNA from one solar keratosis and one SCC, which had earlier been shown to contain RTRX7 (Ho$ pfl et al., 1997) , were cloned in E. coli. Twenty-eight clones from the keratosis and 26 clones from the SCC contained inserts of the expected size and were sequenced. In the keratosis, five different HPV sequences could be detected, RTRX7 was present in 13 clones, HPV-8 was found HIB G. Bens and others G. Bens and others in five clones, and the RTRX3 sequence, recently described by Berkhout et al. (1995) , was found in seven clones. The remaining three clones harboured two different HPV sequences which did not correspond to any type described thus far. An HPV-9-related sequence was found in one clone. In accordance with the nomenclature established by Berkhout et al. (1995) for new EV-type-like sequences from renal transplant recipients, the latter was named RTRX8. Two clones contained a sequence, called RTRX9 (Table 2) , which was related to the previously published sequence of RTRX2 . The SCC harboured three different HPV sequences : 15 of the 26 clones contained RTRX7 and two contained RTRX8. Nine clones harboured a new sequence, designated RTRX10, which showed a close relationship to HPV-22 (Table 2) . Within the different clones containing one distinct HPV type, no sequence variability was observed in this study.
Phylogenetic analyses of the novel HPV L1 sequences (CP66\CP69 amplimers comprising specific sequences of 337-349 bp) and of 26 reference sequences showed that RTRX7-RTRX10 clustered with HPV L1 sequences of the HPV group B1 (Fig. 2) (Chan et al., 1995 ; Myers et al., 1996) . They were located next to the HPV types that were identified as their closest relatives by sequence alignments (Tables 2 and  3) . Bootstrap values of 894, 732, 1000 and 953 were obtained for the branchings of RTRX7-RTRX10, respectively (Fig. 2) . This indicates a high confidence level of the grouping of RTRX7-RTRX10 in the presented tree. The four new sequences could be assigned to different clusters of the HPV group B1 according to the classification of Myers et al. (1996) : RTRX7 to cluster a " , RTRX8 to cluster b " and RTRX10 to cluster b # . RTRX9 clustered with RTRX2, RTRX4 and RTRX5 (Fig. 2) .
The complete genome of RTRX7
RTRX7 appeared to be the predominant HPV sequence in this patient, as demonstrated by direct sequencing (Ho$ pfl et al., 1997) and by the percentage of clones containing this sequence (52 %). Therefore, an attempt was made to determine the sequence of its entire genome from DNA extracts of the SCC. However, it did not prove possible to amplify the complete RTRX7 genome by PCR using outward-directed specific primers binding to the known CP66\CP69 fragment (data not shown). The sensitivity of PCR using tissue material is known to be significantly reduced with increasing length of the PCR product (Ohara et al., 1992 ; Tieben et al., 1993) . Therefore, five additional overlapping subgenomic fragments were amplified and subsequently cloned into pUC18 (Fig. 1 a) . For one end of the desired PCR products, the external and internal primers were derived from the previously determined RTRX7 sequence, beginning with the CP66\CP69 amplimer sequence designated I1 (Fig. 1 a) . The external and internal primers for the other end were degenerate. XbaI and BamHI were used for the cloning of I2-I5 because they were non-cutters of the closest relative of RTRX7, HPV-12. Assuming that the RTRX7 genome persisted in closed circular form in the investigated SCC, the last and longest fragment, I6, was amplified with RTRX7-specific primers derived from the I4 and I5 sequences, respectively. XbaI and BamHI digestion of the I6 PCR product showed cleavage sites of both enzymes within this fragment. I6 was therefore reamplified with SalI linkers at both internal primers.
Fragments I1-I6 were amplified from the SCC which harboured three HPV L1 sequences (RTRX7, RTRX8 and RTRX10). It was therefore possible that I1-I6 could have originated from different HPV genomes. However, the 100 % sequence identities in the 56-120 bp overlaps between adjacent fragments allowed a clear assignment of the six PCR fragments to the genome of one HPV type. Moreover, identical sequences were obtained with each primer set. This indicates that the primers which were absolutely homologous to the previously determined RTRX7 sequences strongly favoured type-specific amplification. Alignments of the sequences of I1-I6 to 74 complete HPV genomes identified HPV-12 as the closest relative in all cases.
Genome organization of RTRX7
The complete genome of RTRX7 was 7731 bp long. The position 1 bp was determined by alignment to the HPV-8 sequence (Fuchs et al., 1986) . The so-called early region covered 52n6 % of the genome and contained the five ORFs E6, E7, E1, E2 and, within E2 in another frame, E4 (Fig. 1 b ; Table  3 ). There was no E5 ORF in RTRX7. The late region represented 40n7 % of the total genome length and consisted of the two ORFs L2 and L1, which code for structural proteins in other papillomaviruses. A short non-coding region (NCR) was located between the ORFs L1 and E6. The organization of the ORFs in RTRX7 was collinear to the genomes of known EVassociated HPVs (Fuchs & Pfister, 1997) . The exact positions of the genomic regions and their coding capacities are summarized in Table 3 . Each ORF of RTRX7 was compared to the respective ORFs of all the other members of the closely related HPV-5 group of viruses . HPV-12 was always the closest relative (Table 3) .
E7 and E1 were the parts of the genome that showed HIC Fig. 2 . Phylogenetic analysis of the new HPV L1 sequences RTRX7-RTRX10. The phylogenetic unrooted tree was calculated according to the neighbourjoining method of Saitou & Nei (1987) (see Methods). The four novel HPV L1 sequences RTRX7-RTRX10 (337-349 bp) and 26 HPV L1 group B1 reference sequences (Myers et al., 1996) (Myers et al., 1996) . RTRX7 was assigned to cluster a 1 , RTRX8 to cluster b 1 , and RTRX10 to cluster b 2 . * Identities with the HPV-12 sequence are given as percentage of matched nucleotides or matched amino acids in a pair of aligned sequences. DNA sequence identities are given first followed by amino acid sequence identities in parentheses. † The E4 ORF does not contain an ATG codon. Therefore, the position of the splice acceptor site for the E1E4 transcript is indicated instead of the first ATG ; coding capacity is calculated from this site.
greatest similarity to published EV-associated HPV types. ORF E4 was the most type-specific region in the RTRX7 sequence, and major gaps had to be introduced to achieve its optimal alignment. It had a higher GC content than any other region of the genome (56n9 % compared to 42n6 % in the complete genome). ORF E4 did not contain an ATG translation initiation codon. The deduced RTRX7 E4 amino acid sequence appears to be proline-rich (22n7 %), which probably makes it a hydrophobic protein with a complex structure. Divergence between the E2 ORF of RTRX7 and that of closely related types was mainly restricted to the central segment coinciding with E4 in another reading frame.
RNA processing signals
Several potential splice donor (SD) and splice acceptor (SA) sites occurred in RTRX7 at positions conserved among EVassociated HPVs (Fig. 1 c) . Their activity in RNA processing has been demonstrated in HPV-5, -8 and -47 (Kiyono et al., 1989 ; Stubenrauch et al., 1992 ; Haller et al., 1995) . The first SD was detected at position 4 within the NCR of RTRX7. This site HID G. Bens and others G. Bens and others Fig. 3 . Alignment of the NCR sequences of RTRX7 and HPV-8. Conserved residues are marked by an asterisk below the aligned sequences. The nucleotide position number is given for the first and the last nucleotide of each line, respectively. Numbering of the HPV-8 sequence was done according to Fuchs et al. (1986) . The potential E2 binding sites P1-P4, the degenerate palindrome Ph, the AT stretch of the early promoter's TATA box, and the conserved sequence motifs M33 and M29 are boxed ; potential binding sites of AP1 and NF1 are indicated in bold ; the translation stop codon of L1 and the start codon of E6 are printed in bold and are underlined. The arrowhead suggests the position of the base exchange in M33 which has been shown by Horn et al. (1993) to reduce enhancer activity in HPV-8.
is used for splicing an NCR exon to an E4 exon in HPV-8. Two other SDs occurred in the E1 ORF of RTRX7 at positions 980 and 1357. Two sites in E4 diverged only slightly from the SD described : one site at position 3607, which is used for the processing of putative L2 transcripts in HPV-5, and another at position 3733 used for splicing an E4 exon to an L1 exon in HPV-8. An SA at position 2674 was homologous to an SA at the 3h end of E1 used for processing E2 transcripts in HPV-5 and -47. Two more potential SAs occurred at position 3326 in E4 and at position 5921 upstream of the translation start codon of L1 (Fig. 1 c) . Homologous sites were used in all investigated HPVs to generate mRNAs for E1FE4 fusion proteins and for L1 proteins.
The RTRX7 sequence contained three polyadenylation signals (AATAAA) followed by possible polyadenylation sites (CAA). They lie at position 145 in the TATA box of the early promoter (see below), at position 4444 at the 5h end of the ORF L2, and at position 7138 in the ORF L1. The one at position 4444 probably represents the polyadenylation signal for early messages. The functional significance of the other two remains to be established.
NCR of RTRX7
The NCR of RTRX7 showed an organization of sequence motifs typical of EV-associated HPVs ( Fig. 3 ; Krubke et al., 1987 ; Ensser & Pfister, 1990) . With 463 bp between the translation termination codon of L1 and the start codon of E6, this region was relatively short compared to the NCR of mucosal HPVs. It contained four copies of palindromic E2 binding sites ACCN '
GGT at positions 7477 (P1), 7567 (P2), 7726 (P3) and 22 (P4), respectively. Another copy was located at position 7400 (P0) at the 3h end of the L1 ORF. A more degenerate palindrome, ACCN ' GTT (Ph), appearing in the NCR sequences of , was found at a homologous position in RTRX7 at nt 7629. A seventh potential E2 binding site, which can also be found in HPV-5 but not in HPV-8 or -12, existed far from the NCR at position 3523 in the E4 ORF. The motifs M29 and M33 (Krubke et al., 1987) and the AP1 binding site were also conserved : compared to HPV-8, there were five nucleotide exchanges in M29, one in M33 and one in the AP1 site (Fig. 3) . Furthermore, RTRX7 showed six potential NF1 binding sites spread between P2 and the M29 motif. A 30 bp long AT stretch was located at position k40 relative to the putative E6 protein translation start codon. It consisted of three TAAA blocks framed by short A\T alterations (Fig. 3) .
Southern blot analysis
In a reconstruction experiment with HPV-8 plasmids, the Southern blot procedure allowed the detection of 0n1 genome HIE equivalent of HPV per cell, if 10 µg DNA was used as input (data not shown). In order to estimate the concentration of RTRX7 DNA in the biopsy material, 10 µg cellular DNA was digested with a non-cutter of RTRX7 and 10 µg with a singlecutter of RTRX7. The tumour DNA was then subjected to homologous Southern blot hybridization with purified labelled I2-PCR products (Table 1) . Although the sensitivity standard for 0n1 genome equivalent per cell was visible, there was no RTRX7-specific signal, in either the non-cut lane or the singlecut lane (data not shown).
Discussion
The analysis of cloned PCR products revealed five different EV-HPV L1 sequences in a premalignant keratosis and three different EV-HPV DNAs in an SCC from a renal transplant recipient. Previous analyses of these biopsies by direct sequencing of PCR products (Ho$ pfl et al., 1997) identified only the RTRX7 sequence, which also prevailed in the majority of clones analysed here. This shows that cloning of PCR products is necessary for a comprehensive evaluation of clinical samples. Of the newly cloned sequences, three (RTRX8-RTRX10) were previously unknown. Alignments with published HPV sequences and phylogenetic analyses allowed their classification as HPV group B1 (EV-HPV) sequences. RTRX7-RTRX10 were distributed into different clusters of group B1 according to Myers et al. (1996) (Fig. 2) . These findings underline the great variety of HPV types associated with premalignant and malignant skin lesions of immunosuppressed patients.
The 246 bp at the 3h end of the determined L1 sequence fragments of RTRX8, RTRX9 and RTRX10 overlap with the 291 bp comprising the MY09-MY11 fragment, which was shown by Chan et al. (1995) to be sufficient for the typing of HPV sequences. RTRX8, RTRX9 and RTRX10 showed only 77n4, 82n6 and 83n7 % sequence identity, respectively, with their closest relative ( Table 2 ). These three isolates are therefore likely to represent new papillomavirus types, but before they can be declared new types their complete genomes need to be cloned.
The entire genome of RTRX7 was cloned from the SCC in six overlapping fragments generated by nested PCR. RTRX7 was closely related to HPV-12, but their DNA sequence identity did not exceed 90 % in the complete L1 ORF (Table 3 ), indicating that RTRX7 can be considered a new HPV type (van Ranst et al., 1996) . According to its similarity with HPVs from the EV-associated group and its genomic organization, RTRX7 can be designated as an EV type, although it has never been detected in a patient with EV thus far.
The fact that overlapping subgenomic fragments from all regions of the RTRX7 genome could be cloned from one biopsy suggests that the viral DNA persists in an episomal state in this SCC. However, the possibility cannot be excluded that PCR products arose from molecules with different physical states or which were differently integrated into the cellular genome. In malignant skin tumours of EV patients, a mixture of monomeric episomes, oligomeric molecules and genomes with deletions or duplications has sometimes been observed (Ostrow et al., 1987 ; Yabe et al., 1989 ; Deau et al., 1991) . All RTRX7-positive clones of PCR products from respective genomic sites of the virus were identical, showing that any noteworthy intratype variety, deletions or duplications are very unlikely in the examined SCC. Episomal persistence of DNA is the rule for HPVs from the EV group in both benign and malignant lesions of EV patients (Orth, 1987) and in the few tumours from non-EV patients analysed by Southern blotting (Lutzner et al., 1983 ; Kawashima et al., 1990 ; Obalek et al., 1992) .
The RTRX7 NCR sequence shared the features of HPV-5, -8 and -36 NCRs according to Ensser & Pfister (1990) . Its AT stretch was 5 bp shorter than that of HPV-8 and 16 bp shorter than that of HPV-12. The reduced size of this element in RTRX7 represented the main difference from the NCR of HPV-12. Horn et al. (1993) found the activity of the late promoter of HPV-8 to be reduced to 15n4 % when a T G point mutation was introduced into the M33 enhancer motif. A T C exchange occurred in RTRX7 at exactly the same position (Fig.  3) . These results give rise to speculation about a reduced activity of the late promoter in RTRX7.
The oncogenic potential of the sequences RTRX7, RTRX8, RTRX9 and RTRX10 remains to be substantiated. Only small amounts of RTRX7 DNA were present in the SCC examined by Southern blot. Hybridization with a homologous probe was used to demonstrate that the RTRX7 DNA concentration was lower than one copy per 10 cells in this biopsy. Although the tumour to stroma cell ratio in the investigated material is unknown, there was probably less than one viral genome copy per cancer cell. Low-level concentrations of viral DNA in EV-HPV-positive skin tumours from non-EV patients seem to be quite common. For this reason, viral DNA has previously been detected only rarely in such cases when Southern blotting was used. Shamanin et al. (1994) examined a set of skin cancer biopsies from immunosuppressed patients by Southern blot and by sequencing of PCR products, and found that the samples containing EV-associated and related HPV types were mostly negative by Southern blot analysis. Considering that RTRX7 was not detected even in a Southern blot experiment with a homologous probe, it is very likely that the negative results in Southern blots are due to the low concentration of viral DNA, and not to the use of inappropriate probes. Persistence of viral DNA at concentrations below one genome copy per cancer cell suggests that the EV-HPV DNA is not necessary for the maintenance of the malignant state. Nevertheless, there may be a kind of ' cross-talk ' operating between HPV DNA-containing tumour cells and their HPV-negative neighbour cells. EV-HPV DNA might, for example, induce the production of cytokines or other messenger substances, stimulating the growth of the adjacent cells.
Knowledge of the complete genome sequence of RTRX7 
